Quick Picks - Shares of ArQule (NASDAQ:ARQL) are being crushed in early trading on Tuesday following an announcement that the company and partner Daiichi Sankyo (OTC:DSNKY) will be … Continue Reading
Read nowMost Popular - A bearish article from theStreet.com is pressuring shares of Hemispherx Biopharma (NASDAQ:HEB) Thursday morning, which comes shortly after the company announced a December 20th FDA … Continue Reading
Read nowQuick Picks - Early Monday, Cell Therapeutics (NASDAQ:CTIC) announced that its JAK2 inhibitor pacritinib demonstrated good tolerability and evidence of cancer-fighting behavior in a 34 patient Phase I … Continue Reading
Read nowLong Ideas - Comments from RW Baird Friday morning point to Merge Healthcare (NASDAQ:MRGE) as a strong stock with near-term value drivers and potential as a take-out candidate. … Continue Reading
Read nowQuick Picks - By Jake King Vivus Inc. (NASDAQ:VVUS) announced Friday morning that, based on preliminary communication with European regulators, the company doubts it will receive approval of … Continue Reading
Read nowLong Ideas - A presentation from Idenix Pharmaceuticals (NASDAQ:IDIX) at the UBS Global Life Sciences conference Thursday did little to settle the nerves of IDIX investors who have … Continue Reading
Read nowLong Ideas - Shares of Aeterna Zentaris (NASDAQ:AEZS) are strong Thursday morning after a Buy initiation from Roth Capital with a $1.75 price target, more than double its … Continue Reading
Read now